The peptides development was ultimately discontinued in 2007 after a 24-week Phase III trial failed to demonstrate statistically significant weight loss compared to placebo, though research into its regenerative properties has continued
RT-qPCR of mouse dorsal skin after treatment further confirmed the upregulation of IGF-1, VEGF, Elastin, and HAS2, while the downregulation of TNF- and IL-1
The dosing below draws from the per-component research and a decade of use informed direction, not a result the blend has been formally measured against
In summary, the dosage and administration of Vitamin B-Complex Injection are flexible and should be tailored by the healthcare provider
always consult a provider
AHK-Cu is for research purposes only and is not intended for human or animal use, diagnosis, treatment, or consumption